인크레틴 유사체-함유 조성물 및 그의 용도

글루코스-의존성 인슐린분비자극 폴리펩티드 (GIP), 글루카곤-유사 펩티드-1 (GLP-1) 및 글루카곤 (GCG) 수용체 각각에서 활성을 갖는 (즉, 삼중-수용체 효능제) 인크레틴 유사체 및 1종 이상의 추가의 작용제, 예컨대 장성 작용제 및 보존제를 포함하는 조성물이 제공된다. 상기 조성물로 질환, 예컨대 제2형 당뇨병, 이상지혈증, 대사 증후군, 비-알콜성 지방간 질환, 비-알콜성 지방간염 및 비만을 치료하는 방법이 또한 제공된다. A composition is provided that includes an incretin a...

Full description

Saved in:
Bibliographic Details
Main Authors GOPALRATHNAM GANAPATHY, MINIE CHRISTOPHER SEARS
Format Patent
LanguageKorean
Published 19.10.2023
Subjects
Online AccessGet full text

Cover

Loading…
Abstract 글루코스-의존성 인슐린분비자극 폴리펩티드 (GIP), 글루카곤-유사 펩티드-1 (GLP-1) 및 글루카곤 (GCG) 수용체 각각에서 활성을 갖는 (즉, 삼중-수용체 효능제) 인크레틴 유사체 및 1종 이상의 추가의 작용제, 예컨대 장성 작용제 및 보존제를 포함하는 조성물이 제공된다. 상기 조성물로 질환, 예컨대 제2형 당뇨병, 이상지혈증, 대사 증후군, 비-알콜성 지방간 질환, 비-알콜성 지방간염 및 비만을 치료하는 방법이 또한 제공된다. A composition is provided that includes an incretin analog having activity at each the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors (i.e., tri-receptor agonist) and one or more additional agents such as a tonicity agent and a preservative. Methods also are provided for treating diseases such as type 2 diabetes mellitus, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and obesity with the composition.
AbstractList 글루코스-의존성 인슐린분비자극 폴리펩티드 (GIP), 글루카곤-유사 펩티드-1 (GLP-1) 및 글루카곤 (GCG) 수용체 각각에서 활성을 갖는 (즉, 삼중-수용체 효능제) 인크레틴 유사체 및 1종 이상의 추가의 작용제, 예컨대 장성 작용제 및 보존제를 포함하는 조성물이 제공된다. 상기 조성물로 질환, 예컨대 제2형 당뇨병, 이상지혈증, 대사 증후군, 비-알콜성 지방간 질환, 비-알콜성 지방간염 및 비만을 치료하는 방법이 또한 제공된다. A composition is provided that includes an incretin analog having activity at each the glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptors (i.e., tri-receptor agonist) and one or more additional agents such as a tonicity agent and a preservative. Methods also are provided for treating diseases such as type 2 diabetes mellitus, dyslipidemia, metabolic syndrome, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and obesity with the composition.
Author MINIE CHRISTOPHER SEARS
GOPALRATHNAM GANAPATHY
Author_xml – fullname: GOPALRATHNAM GANAPATHY
– fullname: MINIE CHRISTOPHER SEARS
BookMark eNrjYmDJy89L5WSwfDN3x9vGNa8XdLzt3qLwZs6CN01r3mzaovt26gogR-HNwg1vWja-XrNH4fWGfoVX23e8mTtD4c2sla_7W3gYWNMSc4pTeaE0N4Oym2uIs4duakF-fGpxQWJyal5qSbx3kJGBkbGBoYmZmYmpozFxqgDOUEGL
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID KR20230146645A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20230146645A3
IEDL.DBID EVB
IngestDate Fri Aug 09 05:01:20 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20230146645A3
Notes Application Number: KR20237032194
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231019&DB=EPODOC&CC=KR&NR=20230146645A
ParticipantIDs epo_espacenet_KR20230146645A
PublicationCentury 2000
PublicationDate 20231019
PublicationDateYYYYMMDD 2023-10-19
PublicationDate_xml – month: 10
  year: 2023
  text: 20231019
  day: 19
PublicationDecade 2020
PublicationYear 2023
RelatedCompanies ELI LILLY AND COMPANY
RelatedCompanies_xml – name: ELI LILLY AND COMPANY
Score 3.474813
Snippet 글루코스-의존성 인슐린분비자극 폴리펩티드 (GIP), 글루카곤-유사 펩티드-1 (GLP-1) 및 글루카곤 (GCG) 수용체 각각에서 활성을 갖는 (즉, 삼중-수용체 효능제) 인크레틴 유사체 및 1종 이상의 추가의 작용제, 예컨대 장성 작용제 및 보존제를 포함하는 조성물이 제공된다....
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 인크레틴 유사체-함유 조성물 및 그의 용도
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20231019&DB=EPODOC&locale=&CC=KR&NR=20230146645A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAbYYgM0Cs1TdpETDJF0ToyRz3SRjSzNdYB5PTgNWaKAmN2i1hZ-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o6NwFaruTjZugb4u_g7qzk723oHqfkFgeVA56SYmZg6MjOwAhvS5qAFYK5hTqB9KQXIlYqbIANbANC8vBIhBqbsfGEGTmfY3WvCDBy-0ClvIBOa-4pFGCzfzN3xtnHN6wUdb7u3KLyZs-BN05o3m7bovp26AshReLNww5uWja_X7FF4vaFf4dX2HW_mzlB4M2vl6_4WUQZlN9cQZw9doBvi4V6O9w5CdrCxGANLXn5eqgSDQloKMNukmQJbFWbmJibGBommKUnAVpSJMVChUVKKuSSDDD6TpPBLSzNwgbigstnQUoaBpaSoNFUWWOmWJMmBwwoA3IuUcg
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQAbYYgM0Cs1TdpETDJF0ToyRz3SRjSzNdYB5PTgNWaKAmN2i1hZ-ZR6iJV4RpBBNDDmwvDPic0HLw4YjAHJUMzO8l4PK6ADGI5QJeW1msn5QJFMq3dwuxdVGD9o6NwFaruTjZugb4u_g7qzk723oHqfkFgeVA56SYmZg6MjOwAhvZFqCT9l3DnED7UgqQKxU3QQa2AKB5eSVCDEzZ-cIMnM6wu9eEGTh8oVPeQCY09xWLMFi-mbvjbeOa1ws63nZvUXgzZ8GbpjVvNm3RfTt1BZCj8GbhhjctG1-v2aPwekO_wqvtO97MnaHwZtbK1_0togzKbq4hzh66QDfEw70c7x2E7GBjMQaWvPy8VAkGhbQUYLZJMwW2KszMTUyMDRJNU5KArSgTY6BCo6QUc0kGGXwmSeGXlmfg9Ajx9Yn38fTzlmbgAkmBymlDSxkGlpKi0lRZYAVckiQHDjcA-pKXYg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=%EC%9D%B8%ED%81%AC%EB%A0%88%ED%8B%B4+%EC%9C%A0%EC%82%AC%EC%B2%B4-%ED%95%A8%EC%9C%A0+%EC%A1%B0%EC%84%B1%EB%AC%BC+%EB%B0%8F+%EA%B7%B8%EC%9D%98+%EC%9A%A9%EB%8F%84&rft.inventor=GOPALRATHNAM+GANAPATHY&rft.inventor=MINIE+CHRISTOPHER+SEARS&rft.date=2023-10-19&rft.externalDBID=A&rft.externalDocID=KR20230146645A